Testing effectiveness (Phase 2)Ended earlyNCT00467077
What this trial is testing
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Who this might be right for
Kidney Cancer
California Cancer Consortium 21